I have to do a more in-depth analysis but here are my thoughts so far - correct me if I am wrong on anything:
1. anti-inflammation drugs a new class, not an NSAID or steroid - and seems not to require FDA approval because it's considered an herbal?? 2. I am huge on making decisions based on what sector the company is in. If #1 above is true - then this company warrants more research. I used to work for Pfizer promoting Celebrex and as you know both Celebrex, Vioxx and the entire COX-2 class got slammed after Vioxx was voluntarily withdrawn. I need to learn more about the product but if the target market is anti-inflammation - there is potentially a huge market out there and explosive growth 3. I see news releases about revenue exploding but needs deeper look into. Will try to do that tomorrow.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.